Neurodevelopmental Disorder Paper
Student name
Instructor name
Course name
Institution name
Date:
Neurological Disorder
The psychological state and enthusiastic prosperity of how an individual carry on, think or feel are viewed as emotional well-being. Nordqvist (2009) recommend that the USA has the most astounding event of people determined to have psychological or cognitive well-being issues Nordqvist (2009). Any neurologic diseases are essentially issue of the spinal cord, nerves, and brain mind that cooperate all through the body. In presence there are no less than 600 noted analyzed neurologic disorders as well as diseases. The chosen neurological disorder detailed in the following includes schizophrenia, anxiety disorder and seizure disorder that are neurodevelopmental, psychological, as well as neurological disorder (Carlson, 2010).
Selected Disorders
The selected neurological disorder elaborated further into is the seizure disorder. The selected psychological disorder XXXXXX to elaborate further XXXX XX XXX anxiety XXXXXXXX. The selected XXXXXXXXXXXXXXXXXX XXXXXXXX selected XX XXXXXXXXX further is schizophrenia. The XXXXXX compares XXX contrasts each XXXXXXXX using XXXXXXXXXXX interventions XXXX XXXXXXX XXXXXXXXX, pharmacological, XXX an XXXXXXXXXXX therapeutic XXXXXXXXX.
Seizure Disorder
Physicians previously XXXXXX seizure disorder epilepsy (Carlson, 2010). Instead, XXX modern XXXXXX seizure disorder is used to refer XX the XXXXXXXXX XXXX XXXX XXXXXX (Carlson, XXXX). XXXXXXX XXXXXXXXX XXX XXX second XXXX important XXXXXXXX of XXXXXXXXXXXX XXXXXXXXX, XXXXXXXX XX a XXXXXX (XXXXXXX, XXXX). X XXXXXXX is XXXXXXXXX as a “sudden XXXXXXXXX XXXXXXXX XX XXXXXXXX XXXXXXX” (XXXXXXX, XX 523, 2010). XXXXXXXX are defined as XXX XXXXXXXX electrical XXXXXXXX that XXXXXXXX periodic episodes XX the brain (Carlson, 2010).
XXX XXXXXXXXXXX intervention for a seizure XXXXXXXXX are treatments that mostly XXXXXXX the use XX XXXXXXXXXXXXXX drugs, which increases the XXXXXXXXXXXXX XX XXX inhibitory XXXXXXXX (Carlson, XXXX). XXXX XXXXXXX XXXXXXXXX XXXXXXX XXXXXXXXXX to anticonvulsant XXXXXXXXXX whereas others do XXX. In a XXX XXXXXXXX XXX seizure disorder medication XXXXX provide no or very XXXXXX help (Carlson, XXXX). XXXXX XXXXXXX XX required when the XXXXXXX XXXX remain XXXXXXXXX XXXX XXXX treatment XXXX not help (Carlson, XXXX). The XXXXXXXXX XX XXXXXX XXX surgeon XXXXXXXX XXXXXXXX of the XXXXXXX XXXXXXXX lobe, XXXXX surrounds the XXXXX XXXXXX XX XXX XXXXX (XXXXXXX, XXXX). Mostly XXXXXXXX rapidly XXXXXXX well with their XXXXXXXX XXXXXXX or eliminated (XXXXXXX, 2010).
XXXXXXX XXXXXXXX
XXXXXXX (XXXX) characterizes XXXXXXX disorders as an unfounded, unrealistic, anxiety, XXX fear. Anxiety XXXXXXXXX are XXXXXXXXXXX defined as a psychological XXXXXXXX, XXXXX XX characterized XX over-XXXXXXXX XX the XXXXXXXXX XXXXXXX XXXXXX, tension, expectation XX an impending XXXXXXXX, or XXX XXXXXXXX vigilance XXX XXXXXX (Carlson, XXXX). The therapeutic intervention XXXX to treat a XXXXXXXX of anxiety disorders are treated using XXXXXXXXXXXXXXX (XXXXXXX, 2010). Common features XX XXXXXXX disorders cause an increase XXXXXXXX XX XXX XXXXXXXX (Carlson, 2010). XXX targets XX XXXXXXXXXXXXXXX XXX the XXXXXXXX, which contains an increase level XX XXXXXXXXXXXXX of XXXXX XXXXXXXXX (Carlson, 2010). XXXXXX XX al. (2005) XXXXXXXX discoveries suggest XXXX XXX XXXXXXXXXXXXXX XX a benzodiazepine XXXXXXXXX the XXXXXXXXXX of XXXXXX and amygdala. Cognitive XXXXXXXX XXXXXXX XX XXXX used XX treat anxiety XXXXXXXXX, XXXXX the XXXXXX uses XXXXXXX XXXXXXXXXX XX desensitize a XXXXXXXX to a XXXXXXXXX or XXXXXX in which the XXXXXXXXXX XXX XXXX (Carlson, 2010).
The XXXXXXXXXX of anxiety XXXXXXXXX are XXXXXXXXXX XXXXX, depending XX XXX particular treatments XXXX XXX XXXXXXXXX XX XXXXX the XXXXXXXX (Smith & XXXXX, XXXX). The XXXXXXXX to the treatment depends XX the severity and XXX XXXXXXXXXXXXX XXXX XX anxiety XXXXXXXX (XXXXX &XXX; XXXXX, XXXX). X majority of anxiety disorders XXX modernly treated XXXX XXXXXXXXXX medication, XXXXXXXXXX XXXXXXX, and a XXXXXXXXXXX XX the XXX therapeutic interventions (XXXXX &XXX; XXXXX, XXXX). Modern research also reveals a number XX XXXXXXXXX XXXXXXXXXX XXXXXXXXXXXXX XXXXXXXXXX XXX XXXXXXX XXXXXXXXX XX individuals in need (XXXXX & Segal, 2011).
XXXXXXXXXXXXX
Carlson (XXXX) technically defines XXXXXXXXXXXXX as a XXXX XXXXXXX mental disorder XXXXXXXXXXXXX XX delusions, XXXXXXXXXX thoughts, XXXXXXXXXXXXXX, and XXXXX-XXXXX XXXXXXX behaviors. The XXXXXXXXXXXXXXXX XXXXXXXX is often-times XXXXXXXXX XX the XXXXXXXXXXX interventions XXXXX XXX atypical XXXXXXXXXXXXX medications, XXXXX reduces XXX positive XXX negative XXXXXXXX XXXXXXXX may XXXXXXXXXX (Carlson, 2010). The XXXXXXXXXX XXXX list includes clozapine, olanzipine, risperidone, XXXXXXXXXXX, and aripiprazole of XXX XXXXXXXX antipsychotic XXXXXXXXXXX (XXXXXXX, 2010).
XXXXXXXX XXXXXXXXXX XXXX Treatment of XXXXXXXXX
XXXXXXXX XXXXXXXX symptoms are treated XXXX an anticonvulsant XXXXX XXX XXXXXXX, which usually XXXXXXXX the XXXXXX temporal lobe XX the brain (XXXXXXX, 2010). Also a change in XXXX is recommended XX patients XXXXXXXXXXX XXX XXXX XX change XXXXXX style XXXX a XXXXXXXXX XXXX to relieve XXXXXXXX (XXXXXXX, 2010). XXX XXXXXXXXX diet is high in fat, XXX in carbohydrate, and moderate in XXXXXXX (XXXXXXX, 2010). XXXXXXXXXXXX XX seizures XXX be XXXXXXX and XXXXX brain damage (Carlson, 2010). XXXXXXX (XXXX) estimates that XXXXXXXXXXXXX 50 percent XX patients with XXXXXXX XXXXXXXXX shows XXXXXX XX the hippocampus. The severity of seizures XXX XXX XXXXXX XX XXXXXX XX correlated XXXX the XXXXXX XXX patient (XXXXXXX, 2010). A single episode XX XXXXXXXXXX XXX cause XXXXXXXXXXX damage by a XXXXXX XXXXXXX (Carlson, 2010). This is XXXXXXXXXX a XXXXXXXXX, which XXX patient may undergo series XX XXXXXXXX without XXXX XXXXXXXXX XXXXXXXXXXXXX (Carlson, 2010).
The XXXXXXXX of an XXXXXXX disorders severely XXXXXXX some XXXXXXXXXXX’ lives (Carlson, 2010). Carlson (2010) XXXXXXXX a XXXXX of a XXXXXX and XXXXX to show that XXXXX XXXXXXXX are XXXXXX heritable, which XXXXXXXXXX a XXXXXXXXXX cause (Carlson, 2010). A XXXXXXXXXX imaging study suggests XXX XXXXXXXXXXX in XXXXXXX XXXXXXXX by XXX amygdala XXX XXX cingulate, XXXXXXXXXX, and insular cortices (XXXXXXX, XXXX). Particular treatments XXXXXX on the severity XX XXX XXXXXXXX XXX the individual XXXXXXX needed XX overcome XXXX. XXXXXXXX from Carlson (2010) XXXXXXXX XXXXXXXX that indicates XXXX XXXXXXX XXXXXXXXX XXX XXXXXX caused XX XXXXXXX XXXXXXXXXX factors.
XXX confirmation XXX XXXXXXXXX of drugs that XXXXXXXXX or XXXXXX symptoms of XXXXXXXXXXXXX has a XXXXXXXXXXXXX effect XX XXX treatment for XXX XXXXXXXX (XXXXXXX, 2010). XXXXXXXX, XXX historically XXXX drugs XX treat schizophrenia XXXX XXXXXX unfamiliar XXXXXXXX that resemble XXXXXXXXX’s disease, XXXXX XXXXXXX the XXXX of facial XXXXXXXXXX, slowness in movement, XXX XXXXXXXX (XXXXXXX, XXXX). Most XXXXXXXX XXXX XXXXXXX in XXXXXXXX XXX temporary (Carlson, 2010). Unfortunately, in XXX-XXXXX of patients whom XXXX the classic anti-schizophrenic XXXXX a more XXXXXXX XXXX XXXXXX developed when the XXXXX XXXXX taken for an XXXXXXXX period of time (Carlson, 2010). With schizophrenia the XXXXXXXX XXX not XX XXXXXXX; it XXX develop or XXXXX XXXXX XXXXX XXXXXX damage such as XXXXXXXXXXXX, XXXXX XXXXXX, XXX head XXXXXX (Carlson, XXXX).
XXXXXX’s Opinion &XXX; XXXXXXXXXXX to Treatment Intervention
XXX XXXXXX XXXXX prefer the XXX of a prescribed XXXXXXXXXX or XXXXXXXXX XXXXXXXXXX along XXXX XXXXXXXXXX therapy XX XXXXXX with the patients’ XXXXXXXXXXXXX XXX XXXX of all XXXXXXXXX. XXX author XXXXX approach the XXXXXXX with XXX disorders XXXX care, XXXXXXX, XXX XXXXXXXXX. The XXXXXX XXXXX XX open XX questions XXX XXXXXX XXXXXXX an XXXXXXXXX of information to XXX XXXXXXX XXX clarity.
Analyze the XXXXXXXXXXXXXXXXXX XXXXXXXXXXXXX XX disorders
XXX neurophysiological mechanisms XX Barb XXX Iragui (XXXX) underlie the XXXXXXX onset, XXXXXXXXXXX, spread, XXX the resistance to pharmacological treatment XXXXXXX largely XXXXXXX. XXX XXXXXXX lobe dysfunctions as XXX XXXXXXX XXXXXXXXXXXXXXXXXX deficit in XXXXXXXX XXXXXXX XXX XXXXXXXXXX of XXXXXXX and XXXXX (1999). Personal XXX public understanding of the XXXXXXXXXXXXX between neurological XXXXXXXXXX XX XXXXXXXXXXXXX XXXXXX XXX nonepileptic XXXXXXXX XXXX XXXXXXX the treatment efficacy XXX enhance XXXXXXXX’ XXXXXXXXX and cognitive functioning (XXXXXXX &XXX; XXXXX, XXXX).
XXX internal XXXXXXXXXXXXXXXXXX state of XXXXXXX is XXXXXXXXXX XX irrational XXX uncontrollable worrying (Earles, 2009). XXXXXXX mental health XXXXXXXXXX are XXXXXXXXXXXXX with underlying XXXXXXX such as the panic attacks, XXXXXXXXXXX anxiety XXXXXXXX (XXX), and XXXXXXXXX compulsive disorder (OCD) (XXXXXX, XXXX).
The XXXXXXXX systems of XXXXXXXXXXXXX physiology principally XXXXXXX XXXXXXXXX, hallucinations, and XXXXXXX disorders (Carlson, XXXX). XXX XXXXXXXX XXX XXXXXXX XX XXX XXXXX functions of XXXXXXXXXXXX neurons: reinforcement (XXXXXXX, 2010). XXX cognitive and XXXXXXXX XXXXXXXX XX schizophrenia are XXXXXXXXX. XXX XXXXXXXX symptoms are XXXXXXXX XXXXX to XXXXXXXXXXXXX, the cognitive and XXXXXXXX symptoms are XXXXXXXXX XX XXXXXXXX produced by brain XXXXXX (Carlson, 2010). Research XXXXXXXX that XXXXX XXXXXXXX of schizophrenia are XXXXXX a result XX XXXXX abnormalities (Carlson, XXXX).
XXXXXXXXXXX XX Contemporary XXXXXXXXX XXXXXX the Treatments XXXXXXXX
XXX XXXXXXXXXXXX attitude XXXXXX a seizure XXXXXXXX is XXXX XXXXXX to XXXXXXXXXX XXXXXXXX XXX XXX disorder XX XXXXXXXXX XXX survival of the XXXXXXX. XXXXXXXXXXX with a XXXXXXX XXXXXXXX are at a greater risk of XXXXXXXXXX and XXXXXXX seizures. Modern diagnosis includes patient referrals to specialist with a particular XXXXXXXXX in epilepsy or XXXXXXX XXXXXXXX XXX a detailed examination and investigation of severity, XXXXXXXX XX XXX XXXXXXXXXX effective monitoring XX XXXXXXXXXX XXX seizure control (Joyce, 1999). XXXXXXXXX expert XXXXXXXXX is XXXXXX and XXXXXXXX XX XXX XXXX available XXXXX and to indicate risk associated XXXX XXXXXXXXXX (Joyce, XXXX).
Several XXX XXXXXXXXXXXX XXXXXXX XXXXXXXXXX are XXXXXXX XXXXXXX as complements XX both therapy XXX XXXXXXXXXX (Smith & Segal, 2011). XX a XXXX anxiety XXXXXXXX patient XXXXX the treatments may provide XXXXXXXXXX relief (XXXXX & Segal, XXXX). Recommendations XXXX been XXXX XX treat XXXXXXX in XXX XXXXXX XXXX exercise, XXXXXXXXXX XXXXXXXXXX, XXXXXXXXXXX, XXX XXXXXXXX (XXXXX &XXX; Segal, 2011).
XXX contemporary attitude toward XXXXXXXXXXXXX from XXXXXXXX discoveries emphasis XXXXXXXXXXXX XXXXXXX XX a XXXXX of XXXXXXXXXXXXX and XXX XXXXXXXXX XX psychotropic XXXXXXXXXX (Haraguchi, XXXX). XXXXXXXX additional XXXXXXX are required to determine to XXXX extent XXX XXXXXXXXXXX XXX XXXXXXXX know about therapeutic procedures process XXXXXXXX XX XXXXXXXXXXXXX (Haraguchi, XXXX). XXXXXXXXXXXXX stronger stigma perception are XXXXX XXXXX the access XXX XXXXXXXXXXXX to institutionalization XX XXXXXXXXX (Haraguchi, 2009).
XXXXXXXXXX
This paper describes XXX XXXXXX neurological, psychological, XXX XXXXXXXXXXXXXXXXXX disorder, which includes seizure XXXXXXXX, XXXXXXX disorder, and XXXXXXXXXXXXX. This XXXXX compares and contrast XXX XXXXXXXXXXX XXXXXXXXXXXXX used to XXXXX XXXX disorder. XXXX paper XXXXXXXXXX XXXXXX symptoms XXXXXXXXXX XXXX each XXXXXXXX XXX the treatment. XXXX XXXXX analyzesXXX neurophysiological XXXXXXXXXXXXX of XXX selected XXXXXXXXX. This XXXXX examines the contemporary attitudes XXXXXX XXX XXXXXXXXXX XXX each XXXXXXXX XXXXXXXXX.
References
Barb, D & Iragui, X. (XXXX).XXXXXX XXXXXXXXX and Synchrony. XX San XXXXX XXXXXX XX Medicine. XXXX://neurosciences.ucsd.edu/2page.XXX?id=NSS
Carlson, N. R. (2010).XXXXXXXXXX of XXXXXXXX. (10th ed.). Boston, XX: XXXXX & Bacon.
XXXXXX, G. (2009).XXX XXX Three: XXXXXXX, Trauma, XXX XXXXXX. http://XXX.XXXXXXXXXXX.com/programs.php#XXXXXXXX
Haraguchi, X. (2009). Stigma associated with schizophrenia: XXXXXXXX comparison of XXXXXX XXXXXXXX in XXXXX XXX China.XXXXXXXXXX XXX XXXXXXXX XXXXXXXXXXXXX 63(X).
XXXXX, X. (1999) Characteristics of XXXXXXXX in a population XXXXX cohort.XXXXX XXXXXXX XX Psychological Medicine, 16, X–9.
XXXXXXXXX, N. (XXXX).What XX XXXXXX XXXXXX? XXXX Is Mental XXXXXXXX? XXXX://www.medicalnewstoday.com/XXXXXXXX/154543.XXX
Smith, X. & XXXXX, X. (XXXX).XXXXXXX, Attacks, XXX Disorders. XXXX://XXXXXXXXX.org/XXXXXX/XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX.XXX
XXXXXXX, E &XXX; XXXXX, X. (XXXX).XXXXXXXXXXXX Seizures: XXXXXXXXXXXXXXXXXX XXXXXXXXXX. Barrow Quarterly. (XXX. 15 no. X). Barrow XXXXXXXXXXXX Institute. XXXXXXX, Arizona.
">